Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Merus (MRUS – Research Report) yesterday and set a price target of ...

Merus (NASDAQ:MRUS – Get Free Report) had its price target hoisted by research analysts at Citigroup from $89.00 to $97.00 in ...

We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In this article, we are going ...

Needham & Company LLC reaffirmed their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $85.00 price target on the ...

Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Merus (MRUS – Research Report) today and set a price target of $96.00. The ...

Get real-time COLLEGEBASKETBALL basketball coverage and scores as Idaho Vandals takes on Oregon State Beavers. We bring you the latest game previews, live stats, and recaps on CBSSports.com ...

Team Rebounds: 1. Team Turnovers: 1. Blocked Shots: 6 (Anderson, Gonzalez, Linhardt, Mims, Mrus). Turnovers: 15 (Anderson 2, Linhardt 2, Payne 2, Steele 2, Yearout 2, Brickner, Gonzalez, Klapper, ...

Fallah 10-16 5-8 25, Rataj 4-12 6-7 14, Kingz 3-8 2-2 9, Lelevicius 4-6 0-0 9, Minor 1-4 0-0 2, Lake 3-4 0-0 8, Sy 2-5 0-0 5, Craig 0-1 0-0 0, Marsh 2-3 0-0 4, Munch 0-1 0-0 0, Logue 0-1 0-0 0, Marrs ...

The campus approval process related to Schools, Colleges, ORUs, and MRUs is not detailed in this document, but will mirror the process for new programs. Contact Mary Laurence, Senior Academic Planning ...

Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or ...

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as ...